Mir7684 Gene Detail

Summary

• Symbol
  Mir7684
• Name
  microRNA 7684
• Synonyms
  mmu-mir-7684

• Feature Type
  miRNA gene
• IDs
  MGI:5531255
  NCBI Gene: 102465786
• Alliance
  gene page

Location &
Maps

• Sequence Map
  Chr15:82278120-82278179 bp, - strand

  From NCBI annotation of GRCm39
  

• View this region in JBrowse
  

• Genome Browsers
  Ensembl | UCSC | NCBI

• Genetic Map
  Chromosome 15, Syntenic
• Mapping Data
  1 experiment

Strain
Comparison

• SNPs within 2kb
  145 from dbSNP Build 142
• Strain Annotations
  1

Strain	Gene Model ID	Feature Type	Coordinates
C57BL/6J	MGI_C57BL6J_5531255	miRNA gene	Chr15:82278120-82278179 (-)
129S1/SvImJ	no annotation
A/J	no annotation
AKR/J	no annotation
BALB/cJ	no annotation
C3H/HeJ	no annotation
C57BL/6NJ	no annotation
CAROLI/EiJ	no annotation
CAST/EiJ	no annotation
CBA/J	no annotation
DBA/2J	no annotation
FVB/NJ	no annotation
LP/J	no annotation
NOD/ShiLtJ	no annotation
NZO/HlLtJ	no annotation
PWK/PhJ	no annotation
SPRET/EiJ	no annotation
WSB/EiJ	no annotation

Homology

• Gene Tree
  Mir7684
  

Human Diseases

• References
  1 with disease annotations

Mutations,
Alleles, and
Phenotypes

• Phenotype Summary
  23 phenotype references
  

• All Mutations and Alleles
  7
• Chemically induced (other)
  1
• Radiation induced
  2
• Targeted
  4
• Genomic Mutations
  7 involving Mir7684
• Find Mice (IMSR)
  2 strains or lines available

Sequences &
Gene Models

• All Sequences
  5
• RefSeq
  1

• Ensembl
  ENSMUSG00000119826 (Evidence)
• NCBI Gene
  102465786

Representative Sequences			Length	Strain/Species
genomic	102465786	NCBI Gene Model | MGI Sequence Detail	60	C57BL/6J
transcript	NR_106153	RefSeq | MGI Sequence Detail	60	ZRU/MplStud

Other Database
Links

miRBase

MI0025033

References

• Summaries
  All 27

  Diseases 1

  Phenotypes 23
• Earliest
  J:7688 Lane PW, et al., Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered. 1984 Nov-Dec;75(6):435-9
• Latest
  J:286122 Henderson CJ, et al., An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials. Drug Metab Dispos. 2019 Jun;47(6):601-615